Clinical Trials Directory

Trials / Completed

CompletedNCT02812979

Evaluation of the Effectiveness of the Nebulization Bronchodilators Under High Nasal Flow Humidified

Evaluation of the Effectiveness of the Nebulization Bronchodilators Under High Nasal Flow Humidified Compared to a Usual Method

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
University Hospital, Tours · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The principal objective is to show noninferiority of nebulized salbutamol through the high flow nasal system moistened AIRVO ™ 2 in terms of reversibility of airflow obstruction compared to nebulization by the usual method (spray mask).

Detailed description

Randomized, comparative, non inferiority study between two nebulization strategies bronchodilators, one according to the method tested namely the spray - in across the top humidified nasal flow system and the other according to a customary procedure, through a mask. A third arm will be evaluated (control arm) to overcome a possible own bronchodilator effect of high flow nasal humidified.

Conditions

Interventions

TypeNameDescription
DEVICEAirvo2 with Aerogen SoloNebulization of salbutamol with Airvo 2 and Aerogen solo
DEVICEMaskUsual nebulization of salbutamol with mask
DEVICEarm control Airvo2 without nebulization of salbutamolAirvo2 with Aerogen Solo. No nebulization of salbutamol

Timeline

Start date
2016-06-01
Primary completion
2018-04-27
Completion
2018-04-27
First posted
2016-06-24
Last updated
2025-12-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02812979. Inclusion in this directory is not an endorsement.